Isabel Martínez-Lacaci

1.2k total citations
30 papers, 992 citations indexed

About

Isabel Martínez-Lacaci is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Isabel Martínez-Lacaci has authored 30 papers receiving a total of 992 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 21 papers in Oncology and 6 papers in Genetics. Recurrent topics in Isabel Martínez-Lacaci's work include HER2/EGFR in Cancer Research (9 papers), Estrogen and related hormone effects (5 papers) and Cancer-related Molecular Pathways (5 papers). Isabel Martínez-Lacaci is often cited by papers focused on HER2/EGFR in Cancer Research (9 papers), Estrogen and related hormone effects (5 papers) and Cancer-related Molecular Pathways (5 papers). Isabel Martínez-Lacaci collaborates with scholars based in Spain, United States and Germany. Isabel Martínez-Lacaci's co-authors include Miguel Saceda, Estefanía Carrasco‐García, Pilar García-Morales, David S. Salomon, Caterina Bianco, José A. Ferragut, Brenda Wallace‐Jones, Andreas D. Ebert, Christian Wechselberger and Robert B. Dickson and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Endocrinology.

In The Last Decade

Isabel Martínez-Lacaci

30 papers receiving 981 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabel Martínez-Lacaci Spain 20 698 409 141 131 104 30 992
Tim P. Green United Kingdom 13 699 1.0× 504 1.2× 95 0.7× 133 1.0× 109 1.0× 14 1.2k
M V Blagosklonny United States 9 574 0.8× 426 1.0× 190 1.3× 130 1.0× 117 1.1× 11 989
Kevin P. Rice United States 8 707 1.0× 605 1.5× 65 0.5× 170 1.3× 85 0.8× 10 1.1k
Xiao-Feng Le United States 21 910 1.3× 462 1.1× 99 0.7× 274 2.1× 105 1.0× 23 1.3k
Rumey C. Ishizawar United States 8 600 0.9× 436 1.1× 134 1.0× 111 0.8× 66 0.6× 13 1.1k
R. Gätje Germany 16 507 0.7× 291 0.7× 134 1.0× 206 1.6× 93 0.9× 24 865
Weiguo Wu United States 16 601 0.9× 314 0.8× 80 0.6× 152 1.2× 69 0.7× 33 978
Honor J. Hugo Australia 15 520 0.7× 433 1.1× 91 0.6× 238 1.8× 83 0.8× 29 927
Richard A. Woo Canada 10 674 1.0× 454 1.1× 165 1.2× 153 1.2× 47 0.5× 11 893
Joan MacNeill United States 6 841 1.2× 303 0.7× 123 0.9× 135 1.0× 37 0.4× 6 1.1k

Countries citing papers authored by Isabel Martínez-Lacaci

Since Specialization
Citations

This map shows the geographic impact of Isabel Martínez-Lacaci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabel Martínez-Lacaci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabel Martínez-Lacaci more than expected).

Fields of papers citing papers by Isabel Martínez-Lacaci

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabel Martínez-Lacaci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabel Martínez-Lacaci. The network helps show where Isabel Martínez-Lacaci may publish in the future.

Co-authorship network of co-authors of Isabel Martínez-Lacaci

This figure shows the co-authorship network connecting the top 25 collaborators of Isabel Martínez-Lacaci. A scholar is included among the top collaborators of Isabel Martínez-Lacaci based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabel Martínez-Lacaci. Isabel Martínez-Lacaci is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pereira, Gustavo J.S., Andrana K. Calgarotto, Isabel Martínez-Lacaci, et al.. (2016). Autophagy regulates Selumetinib (AZD6244) induced-apoptosis in colorectal cancer cells. European Journal of Medicinal Chemistry. 122. 611–618. 28 indexed citations
2.
Martínez, Carlos, et al.. (2015). Association of a characteristic membrane pattern of annexin A2 with high invasiveness and nodal status in colon adenocarcinoma. Translational research. 166(2). 196–206. 15 indexed citations
3.
Martínez-García, Jerónimo, et al.. (2015). 455 Reversal of azd6244 (selumetinib) resistance in primary cultures of colorectal cancer, by p70s6 kinase inhibition using bez-235. European Journal of Cancer. 51. S96–S97. 1 indexed citations
4.
Carrasco‐García, Estefanía, Pilar García-Morales, Miguel Saceda, et al.. (2014). Comparative Study of 17-AAG and NVP-AUY922 in Pancreatic and Colorectal Cancer Cells: Are There Common Determinants of Sensitivity?. Translational Oncology. 7(5). 590–604. 28 indexed citations
5.
Carrasco‐García, Estefanía, Miguel Saceda, Lourdes Rocamora‐Reverte, et al.. (2011). Small tyrosine kinase inhibitors interrupt EGFR signaling by interacting with erbB3 and erbB4 in glioblastoma cell lines. Experimental Cell Research. 317(10). 1476–1489. 45 indexed citations
6.
Martínez-Lacaci, Isabel, Pilar García-Morales, José Luís Soto, & Miguel Saceda. (2007). Tumour cells resistance in cancer therapy. Clinical & Translational Oncology. 9(1). 13–20. 23 indexed citations
7.
García-Morales, Pilar, Estefanía Carrasco‐García, María Piedad Menéndez-Gutierrez, et al.. (2007). Inhibition of Hsp90 function by ansamycins causes downregulation of cdc2 and cdc25c and G2/M arrest in glioblastoma cell lines. Oncogene. 26(51). 7185–7193. 56 indexed citations
8.
Menéndez-Gutierrez, María Piedad, Estefanía Carrasco‐García, Pilar García-Morales, et al.. (2007). Protein kinase C-alpha antagonizes apoptosis induction by histone deacetylase inhibitors in multidrug resistant leukaemia cells. The International Journal of Biochemistry & Cell Biology. 39(10). 1877–1885. 8 indexed citations
9.
García-Morales, Pilar, Eva Hernando, Estefanía Carrasco‐García, et al.. (2006). Cyclin D3 is down-regulated by rapamycin in HER-2-overexpressing breast cancer cells. Molecular Cancer Therapeutics. 5(9). 2172–2181. 33 indexed citations
10.
García-Morales, Pilar, Ángeles Gómez‐Martínez, Alfredo Carrato, et al.. (2005). Histone deacetylase inhibitors induced caspase-independent apoptosis in human pancreatic adenocarcinoma cell lines. Molecular Cancer Therapeutics. 4(8). 1222–1230. 53 indexed citations
11.
Ebert, Andreas D., Christian Wechselberger, Matthias Nees, et al.. (2000). Cripto-1-Induced Increase in Vimentin Expression Is Associated with Enhanced Migration of Human Caski Cervical Carcinoma Cells. Experimental Cell Research. 257(1). 223–229. 46 indexed citations
12.
Martínez-Lacaci, Isabel, Caterina Bianco, Masaharu Seno, et al.. (2000). Cripto-1 induces apoptosis in HC-11 mouse mammary epithelial cells. Cell Death and Differentiation. 7(2). 189–196. 11 indexed citations
13.
Martínez-Lacaci, Isabel, Marta De Santis, Caterina Bianco, et al.. (2000). RAS transformation causes sustained activation of epidermal growth factor receptor and elevation of mitogen-activated protein kinase in human mammary epithelial cells. International Journal of Cancer. 88(1). 44–52. 30 indexed citations
14.
Ebert, Andreas D., Christian Wechselberger, Stephan Frank, et al.. (1999). Cripto-1 induces phosphatidylinositol 3'-kinase-dependent phosphorylation of AKT and glycogen synthase kinase 3beta in human cervical carcinoma cells.. PubMed. 59(18). 4502–5. 52 indexed citations
15.
Bianco, Caterina, Marta De Santis, Masaharu Seno, et al.. (1999). Cripto-1 Indirectly Stimulates the Tyrosine Phosphorylation oferb B-4 through a Novel Receptor. Journal of Biological Chemistry. 274(13). 8624–8629. 65 indexed citations
16.
Santis, Marta De, Jean‐Pierre David, Gilbert H. Smith, et al.. (1997). Cripto Enhances the Tyrosine Phosphorylation of Shc and Activates Mitogen-activated Protein Kinase (MAPK) in Mammary Epithelial Cells. Journal of Biological Chemistry. 272(6). 3330–3335. 87 indexed citations
17.
Martínez-Lacaci, Isabel, Gibbes R. Johnson, David S. Salomon, & Robert B. Dickson. (1996). Characterization of a novel amphiregulin-related molecule in 12-O-tetradecanoylphorbol-13-acetate-treated breast cancer cells. Journal of Cellular Physiology. 169(3). 497–508. 15 indexed citations
18.
Martínez-Lacaci, Isabel & Robert B. Dickson. (1996). Dual regulation of the epidermal growth factor family of growth factors in breast cancer by sex steroids and protein kinase C. The Journal of Steroid Biochemistry and Molecular Biology. 57(1-2). 1–11. 16 indexed citations
19.
Normanno, Nicola, WJ Gullick, Graziella Persico, et al.. (1993). EXPRESSION OF AMPHIREGULIN, CRIPTO-1, AND HEREGULIN-ALPHA IN HUMAN BREAST-CANCER CELLS. International Journal of Oncology. 2(6). 903–911. 55 indexed citations
20.
Bano, Mozeena, Eric Shi, Junichi Kurebayashi, et al.. (1992). Growth factors in breast cancer: Mitogenesis to transformation. The Journal of Steroid Biochemistry and Molecular Biology. 43(1-3). 69–78. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026